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form mammospheres in culture, lower mammary outgrowth potential when transplanted into cleared fat pads, and
reduced appearance of tumor-initiating CD29hiThy1+CD24+ cells, than in those of control diet-fed mice. Diet had no comparable
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1150 O.M. Rahal et al.revealed markedly altered expression of genes important to inflammation, cytokine and chemokine signaling, and
proliferation. Soy-fed relative to casein-fed mice showed lower mammary tumor incidence, shorter tumor latency, and reduced
systemic levels of estradiol 17-β, progesterone and interleukin-6. Our results provide evidence for the functional impact of
diet on specific epithelial subpopulations that may relate to breast cancer risk and suggest that diet-regulated cues can be further
explored for breast cancer risk assessment and prevention.
© 2013 Elsevier B.V. All rights reserved.IntroductionBreast cancer is a heterogeneous disease characterized by at
least eighteen histopathological and six distinct molecular
subtypes, making it extremely difficult to treat (Sørlie et al.,
2001). This phenotypic diversity is considered to reflect the
epithelial lineage from which a given breast cancer
originates (Sørlie et al., 2001; Lim et al., 2009). Although
the molecular understanding of the earliest events contrib-
uting to breast cancer remains unclear, it is increasingly
apparent that a small population of self-renewing epithelial
cells in the mammary glands (designated mammary stem
cells; MaSC) can undergo oncogenic transformations, there-
by, endowing these transformed cells (designated cancer
stem cells, CSC) with tumor-initiating properties and the
ability to persist in tumors as a distinct population (Al-Hajj
et al., 2003; Stingl et al., 2006; Clarke, 2008; Visvader,
2009). CSC and their normal MaSC counterparts are consid-
ered to share regulatory programs for their maintenance and
propagation. Signaling pathways mediated by Wnt, Notch,
Hedgehog, and phosphatidylinositol 3-kinase/Akt have been
identified as critical for growth control of normal MaSC and
when de-regulated, may underlie aberrant CSC self-renewal
and multi-differentiation (Li et al., 2003; Liu et al., 2006;
Farnie and Clarke, 2007; Korkaya et al., 2009). Given recent
findings of the dynamic plasticity of normal SC and CSC-like
cells (Chaffer et al., 2011); that both luminal and myoepi-
thelial (basal) cells can equally contribute to epithelial
regeneration (Van Keymeulen et al., 2011); and that luminal
and basal epithelial signatures are tightly maintained by
autocrine and paracrine-signaling mechanisms (Balko et al.,
2012), the identification of novel factors that alter the
expansion and biology of epithelial subpopulations has signif-
icant implications for breast cancer prevention and treatment.
Diet and lifestyle are highly modifiable determinants of
breast cancer risk. In support of this, clinical and epidemi-
ological investigations have demonstrated an inverse asso-
ciation between high soy food intake and breast cancer
susceptibility (Fink et al., 2007; Wu et al., 2008), with the
strongest and most consistent association demonstrated
when dietary intake occurred during early childhood than
at any other life stage (Korde et al., 2009). Nevertheless,
the molecular mechanisms underlying the linkage between
diet and breast cancer risk remain poorly understood, in part
because translating epidemiological data to clinical (human)
studies and equating these with experimental evidence from
animal models of breast cancer has not been completely
straightforward. Previously, we showed that dietary intake
of soy-rich foods reduced chemically-induced mammary
tumor formation in rodent models, partly through inhibition
of Wnt-signaling and upregulation of PTEN expression
(Simmen et al., 2005; Dave et al., 2005; Su et al., 2007; Su
and Simmen, 2009; Rahal and Simmen, 2010). Using thehuman breast cancer cell lines MCF-7 and MDA-MB-231 that
display a subpopulation of cells with SC-like properties, we
further showed that the soy isoflavone genistein can limit the
expansion and differentiation potential of this subpopulation,
asmeasured by their decreased ability to formmammospheres
when cultured under non-adherent conditions (Montales
et al., 2012). Since PTEN and Wnt signaling pathways are
functionally linked (Li et al., 2003; Korkaya et al., 2009) and
constitute key regulators of mammary SC and CSC biology (Liu
et al., 2004; Farnie and Clarke, 2007; Zhou et al., 2007;
Korkaya et al., 2009), our findings raise the intriguing
possibility that epithelial cells with mammosphere-forming
activities, suggestive of regenerative potential, are early in
vivo targets of dietary factors for anti-tumor protection.
Little is known about the influence of diet on specific
mammary epithelial populations in vivo. To investigate this,
we evaluated the relative frequency and functional behavior
of distinct epithelial subpopulations in pre-neoplastic (hy-
perplastic) mammary tissues of MMTV-Wnt1-transgenic mice
(Tsukamoto et al., 1988) by using well-characterized cell-
surface antigens for fluorescence-activated cell sorting
(FACS) and soy-based foods as dietary paradigm. Wnt1-Tg
female mice are prone to spontaneous mammary tumors due
to SC expansion (Cho et al., 2008; Vaillant et al., 2008).
Hyperplastic mammary glands from these mice display
increased repopulating activity while resultant mammary
tumors show enhanced accumulation of CSC with tumor-
initiating ability. We show here that the frequency of
CD29hiCD24+Lin− epithelial cells, unlike that of the
CD29loCD24+Lin− is reduced in hyperplastic mammary glands
of Wnt1-Tg mice exposed to dietary soy protein isolate (SPI)
beginning at weaning and throughout lifetime when com-
pared to those of mice fed the control diet. We also show
that the reduction of this epithelial subpopulation with
dietary SPI exposure is associated with decreased self-
renewal capacity and lower outgrowth potential of mam-
mary epithelial cells and reduced mammary tumor inci-
dence. Gene expression profiling of this mammary epithelial
subpopulation further revealed a suppressed transcriptional
network important to inflammation, cytokine and chemo-
kine signaling, and proliferation. Our results provide evi-
dence for the functional impact of diet on specific epithelial
subpopulations that may relate to breast cancer risk and
suggest that diet-regulated cues can be further explored for
breast cancer risk assessment and prevention.
Materials and methods
Animals and diets
Animal studies were carried out in accordance with ap-
proved protocols from the University of Arkansas for Medical
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were housed in polycarbonate cages under conditions of
24 °C, 40% humidity and a 12-h light, 12-h dark cycle. Wnt1
transgenic (Wnt1-Tg) male mice [B6SJL-Tg(Wnt1)1Hev/J]
were obtained from Jackson Laboratories (Bar Harbor,
Maine, USA) and mated with wildtype (WT) females of the
same strain to generate both WT and Wnt1-Tg offspring.
During mating and throughout pregnancy and lactation,
dams were fed the American Institute of Nutrition
(AIN-93G)-based diet containing casein (CAS) as the sole
protein source (Simmen et al., 2005). At weaning [post-natal
day (PND) 21], female Wnt1-Tg mice were assigned to one of
the two semi-purified isocaloric AIN-93 based diets with
either CAS or soy protein isolate (SPI; containing 430 mg of
total isoflavones/kg diet) as sole protein source. Food and
water were provided ad libitum. Spontaneous mammary
tumor formation was monitored in Wnt1-Tg mice (n = 30 per
diet group) by weekly palpation from four weeks of age until
8 months (Fig. 1a). Tumors were measured using a caliper at
initial detection, and 2 weeks later, were excised, weighed,
and re-measured. Tumor volume was calculated as previ-
ously described (Rahal et al., 2013). Mice which did not
manifest tumors at age 8 months were euthanized.
Whole mount analyses
Whole mounts of mammary fat pads were prepared and
analyzed for branching density and numbers of terminal
end buds (TEBs) following previously described procedures
(Rahal et al., 2013). Four to five mice were used for each
diet group.
Isolation of primary mammary epithelial cells
Primary mammary epithelial cell (MEC) isolation followed
previously described procedures (LaMarca et al., 2010).
Briefly, MECs were isolated from hyperplastic mammary
glands (#3–5; without lymph nodes) of PND75 Wnt1-Tg mice
fed either CAS or SPI beginning at weaning (PND21) (Fig. 1a).
The glands were mechanically minced until pasty and
digested with collagenase A (2 mg/ml/0.1 g tissue) (Roche
Applied Science, Indianapolis, IN) in DMEM/F12 containing 1×
antibiotic–antimycotic (ABAM; Invitrogen, Carlsbad, Califor-
nia, USA) at 37 °C for 1 h in a rotary shaker at 200 rpm.
Samples were centrifuged at 600 ×g for 10 min, washed three
times in wash buffer [DMEM/F12, 5% fetal bovine serum
(FBS), and 1% ABAM (all from Invitrogen)] at 425 ×g for 2 s
and then once in PBS before trypsinization in 0.05% Trypsin/
EDTA (Invitrogen) for 20 min. Trypsin was diluted in HBSS+
[HBSS (Invitrogen) containing 2% FBS and 10 mmol/L HEPES
(Invitrogen)]. Cells were filtered through a 40 μm strainer,
centrifuged at 450 ×g for 5 min, and washed once in HBSS+
prior to use for further analyses (Fig. 1a).
Fluorescence activated cell sorting (FACS)
Freshly isolated MECs were resuspended in HBSS+
(1 × 107 cells/ml) and labeled with selected antibodies or
isotype controls (Supplementary Table S1) for 30 min on
ice. Cells were then washed in HBSS+ and incubated with
streptavidin–APC. After incubation for 20 min on ice, cellswere washed once with HBSS+ and then subjected to FACS
on a FACS Aria Cell Sorting Flow Cytometer (BD Bioscience,
San Jose, California, USA) (Supplementary Fig. S2). Dead
cells were excluded using 4′,6-diamidino-2-phenylindole
(DAPI; 1 μg/ml; Sigma–Aldrich, St. Louis, MO). Cell purity
was routinely greater than 95%. Data analysis was performed
using FACS Diva software (BD Bioscience).
Mammosphere and colony assays
Freshly isolated MECs from hyperplastic mammary glands of
PND75 Wnt1-Tg mice fed either CAS or SPI or FACS-sorted
epithelial subpopulations were used for both mammosphere
and colony forming assays. Mammosphere culture was
performed as previously described (Montales et al., 2012).
Cells were grown in non-adherent culture dishes and allowed
to form primary mammospheres (P1). After 5 days, primary
mammospheres were collected, dissociated into single cells
and plated for formation of secondary mammospheres (P2).
Mammosphere-forming units (MFUs) were manually counted
at day 5 and day 7 of primary and secondary passages,
respectively. Matrigel colony forming assay followed previ-
ously described protocols (Stingl et al., 2006). Colonies (per
5000 seeded cells) were counted on day 14 of culture. Results
shown for isolated MECs are from seven (mammosphere
assay) and five (colony assay) independent experiments, with
each experiment representing mammary epithelial cells
isolated from a different mouse and performed in 8–16
replicates. Mammosphere-formation and clonogenic assays
of FACS-sorted cells are from three independent experi-
ments, with each experiment representing an individual
mouse and carried out in triplicates.
MEC transplantation assays
MECs isolated from hyperplastic mammary glands of PND75
Wnt1-Tg mice (donor; n = 8 each for CAS and SPI groups)
were suspended at a concentration of 10,000 cells/10 μl in a
1:1 solution of PBS and Matrigel (BD Bioscience) (LaMarca
et al., 2010). For each donor mouse, 10 μl of suspended
MECs was injected into cleared fat pads of an individual
recipient (PND21) wildtype mouse (CAS-MECs on right side;
SPI-MECs on left side) using a 26 G needle attached to a 50 μl
Hamilton glass syringe (Hamilton Company, Reno, Nevada,
USA). Recipient mice (total of 8) were lifetime fed the
control CAS diet and sacrificed 8 weeks after transplanta-
tion. Left and right mammary glands (#4) for each injected
mouse were collected for whole mount analysis as previously
described (Rahal et al., 2013).
Microarray analysis
Total RNA was isolated from freshly sorted CD29hiCD24+Lin−
epithelial subpopulation of hyperplastic mammary glands
(#3–5) of PND75 Wnt1-Tg mice fed either CAS or SPI, using
the Arcturus PicoPure RNA isolation kit (Life Technologies
Corporation, Carlsbad, California, USA). RNA (100 ng) was
amplified using the 3′ IVT Express kit (Affymetrix, Santa
Clara, California, USA) prior to hybridization onto Affymetrix
430 2.0 array chips, which contain over 45,000 probes
interrogating 34,000 well-characterizedmouse genes. Isolated
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Figure 1 Description of the animal model and experimental design. (a) Overview of the dietary regimen and subsequent analyses.
Wildtype female mice were mated with Wnt1-Transgenic (Tg) males to generate wildtype and Wnt-1 Tg offspring. Female Wnt1-Tg
mice at weaning [postnatal day (PND) 21] were randomly assigned to either casein (CAS) or soy protein isolate (SPI) diets and were fed
their respective diets thereafter. Mice (n = 30 mice per diet group) were followed for mammary tumor appearance (by palpation),
and those with tumors were sacrificed two weeks after initial tumor appearance. Mice that did not develop tumors were sacrificed at
8 months of age. A similar set of mice were sacrificed at postnatal day (PND) 75 for the conduct of the various assays shown.
Abbreviations used: GD4, gestation day 4; MEC, mammary epithelial cells; FACS, fluorescence-activated cell sorting; and QPCR,
quantitative real-time polymerase chain reaction. (b) Representative carmine-stained whole mounts of mammary glands
(left mammary gland #4) from Wnt1-Tg females and their wildtype (WT) siblings of the two diet groups. Wnt1-Tg and WT mice
were fed either CAS or SPI diet beginning at PND21 (weaning) and mammary tissues at PND50 were collected for the analyses,
following previously described procedures (Rahal et al., 2013). (c) Mammary ductal branching and terminal end buds (TEBs) were
quantified in PND50 Wnt1-Tg mice of the two diet groups. Branching density for each gland was quantified by counting the number of
branched points within a box of fixed dimensions. The TEBs located at the leading edge of the fat pad were counted from whole
mounts of the left mammary gland #4. Results are mean ± SEM (n = 5 and 4 individual mice, respectively for CAS and SPI diets).
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constituted one biological replicate; two independent biolog-
ical replicates (representing a total of 6–8 independent RNA
samples per diet group) were used for the array analyses.
Expression data was analyzed using the GeneSpring GX version
11 software (Agilent Technologies, Santa Clara, California,
USA). Processing of the .CEL files was performed using the
GeneChip robust multiarray analysis (RMA) with quantile
normalization as previously described (Pabona et al., 2012).
Additional gene expression analysis was performed using
genome set enrichment analysis (GSEA) (Subramanian et al.,
2005). Ontology and biological function analyses used the
GeneSpring and Affymetrix NetAffx programs; genes with at
least 1.3-fold change (P ≤ 0.05) were analyzed using Ingenu-
ity Pathway Analysis (IPA; Ingenuity Systems, Redwood City,
California, USA). Data were deposited in Gene Expression
Omnibus (GSE37849).
Quantitative real-time PCR (QPCR)
Preparation of cDNAs and QPCR analyses was performed
as described (Rahal and Simmen, 2010). Primers (Supple-
mentary Table S3) were synthesized by Integrated DNA
Technologies, Inc. (Coralville, Iowa, USA). mRNA expression
was calibrated to a standard curve generated using pooled
cDNA stocks and normalized to that of TATA-box binding
protein (Tbp) or 18s rRNA.
Serum analysis for steroid hormones and IL6
Analyses were carried out using sera collected from PND75
Wnt1-Tg mice assigned for FACS, mammosphere, colony-
forming, and transplantation assays (Fig. 1a). Estradiol
levels (n = 15 mice per diet group) were quantified using
an Estradiol Ultrasensitive RIA Kit (Beckman Coulter Inc.,
Brea, California, USA). IL6 levels (n = 13 mice per diet
group) were measured using a Mouse IL6 Quantikine ELISA Kit
(R&D Systems, Inc., Minneapolis, Minnesota, USA). Proges-
terone levels (n = 8 mouse per diet group) were determined
using a Progesterone EIA Kit (Cayman Chemical Company,
Ann Arbor, Michigan, USA).
Statistical analysis
Data are presented as mean ± SEM and were compared by
t-test or one way ANOVA, using the SigmaStat 3.5 software
(SPSS, Chicago, Illinois, USA). Differences in tumor incidence
between diet groups were determined by Fisher's Exact test.
P ≤ 0.05 was considered to be statistically significant.
Results
Dietary SPI lowers the relative frequency of the
CD29hiCD24+Lin− epithelial subpopulation in
hyperplastic mammary glands of Wnt1-Tg mice
Whole mounts of mammary glands from Wnt1-Tg virgin mice
(PND50) displayed extensive ductal side-branching and
highly developed lobuloalveoli relative to same-aged wild-
type (WT) mice and did not visibly differ with CAS and SPIdietary exposure (Fig. 1b). This was supported by the
comparable numbers of ductal branching points and terminal
end buds in Tg mammary glands of both diet groups (Fig. 1c).
Diet did not also alter the MEC yield from these tissues
(8.29 ± 1.12 × 106 vs. 8.03 ± 1.38 × 106 cells/g of mammary
tissue; CAS vs. SPI, respectively).
To investigate whether diet can alter the frequency of
distinct epithelial subpopulations, we analyzed hyperplastic
mammary glands of PND75 Wnt1-Tg virgin mice fed CAS
(control) or SPI diets beginning at weaning. Epithelial sub-
populations between the two diet groups were quantified by
FACS, based on the expression of cell surface antigens CD29
(β1 integrin) and CD24 (heat stable antigen) within the lineage
negative (Lin−) population (CD45−, TER119−, CD31−); these
markers have been previously shown to distinguish basal from
luminal epithelial cells (Stingl et al., 2006; Clarke, 2008;
Visvader, 2009). The basal (MaSC-enriched) subpopulation
(CD29hiCD24+) was decreased by ~40% (P =0.009) in hyper-
plastic mammary glands of Wnt1-Tg mice fed SPI relative
to those fed CAS (Figs. 2a, b). By contrast, the luminal
(CD29loCD24+) subpopulation did not differ between the
dietary groups (Figs. 2a, c). Further fractionation of the
MaSC-enriched population using the surface marker Thy1,
which was shown previously to distinguish the CSC (tumor-
initiating) population (CD29hiThy1+CD24+) inWnt1-Tgmammary
tumors (Cho et al., 2008), resulted in the isolation of a very
small cell fraction (~1%) from the total bulk of hyperplastic
epithelial cells in the CAS-fed group. This cell pool was reduced
(by 2-fold; P = 0.012) in epithelial cells isolated from hyper-
plastic mammary glands of corresponding SPI-fed Wnt1-Tg mice
(Fig. 2d). Results demonstrate that SPI diet can alter the
relative frequency of distinct epithelial subpopulations in
mouse mammary glands overexpressing Wnt1 oncogene.
Dietary SPI exposure decreases systemic levels
of progesterone and estradiol
While both human and mouse MaSCs lack estrogen receptor
and progesterone receptor expression, MaSC activity is
under hormonal regulation via paracrine signaling from the
luminal compartment (Asselin-Labat et al., 2006, 2010;
Joshi et al., 2010). To determine if the specific reduction in
the frequency of the basal (MaSC) subpopulation by dietary
SPI is correlated with systemic changes in the hormonal
milieu, serum levels of estradiol-17β and progesterone were
measured in PND75 Wnt1-Tg mice that were used as a source
of hyperplastic mammary glands for FACS analyses. Levels of
progesterone were lower (by 2.2-fold) in SPI- than in CAS-fed
Wnt1-Tg mice (Fig. 2e). Similarly, serum estradiol-17β
concentrations were lower (by 2.6-fold) in SPI- than in the
CAS-fed group (Fig. 2f). Thus, dietary SPI effects on the
frequency of the basal (CD29hiCD24+) population may involve
changes in systemic steroid hormone levels.
Dietary SPI protects against spontaneous mammary
tumor formation in Wnt1-Tg mice
To evaluate whether the reduction in the frequency of
the basal (CD29hiCD24+Lin−) population within hyperplastic
mammary glands can be associated with lower risk for
mammary tumors, Wnt1-Tg female mice fed CAS or SPI
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Figure 2 Dietary SPI reduces the frequency of the MaSC-enriched (CD29hiCD24+Lin) epithelial subpopulation in hyperplastic
mammary glands of Wnt1-Tg mice. (a) Representative FACS plot of mammary epithelial cells (MECs) from hyperplastic mammary
glands of PND75 Wnt1-Tg mice fed CAS (left) or SPI (right). Basal and luminal epithelial sub-populations were identified based on their
expression of mouse cell surface markers CD29 and CD24 within the lineage negative (CD45−, TER119−, and CD31−) population after
exclusion of dead cells (DAPI+). The gating strategy for FACS analyses is presented in Supplementary Fig. S2. (b) SPI diet reduced
MaSC-enriched (CD29hiCD24+) epithelial sub-population; *P = 0.009. (c) Diet had no effect on luminal (CD29loCD24+) epithelial
sub-population. (d) SPI reduced the Thy1+CD24+CD29hi (CSC) sub-population in hyperplastic mammary tissue of Wnt1-Tg mice.
*P = 0.012 relative to CAS. Data shown (for panels b–d) are from at least 5–7 independent experiments, with each experiment
representing pooled MECs isolated from 2 to 3 mice for each diet group. Serum levels of progesterone (e) and estradiol 17-β (f) of
PND75 Wnt1-Tg female mice fed CAS or SPI were quantified as described under Materials and methods. *P = 0.001.
1154 O.M. Rahal et al.beginning at weaning and throughout their lifetime were
followed for formation of tumors for a period of 8 months
(Fig. 1a). The study closure was set a priori at age 8 months
to allow for optimal tumor development, given that only
~50% of Wnt-Tg female mice develop mammary tumors by
age 5–6 months (Tsukamoto et al., 1988). Approximately
one-half (47%) of Wnt1-Tg mice fed SPI (from a total of 30
mice) were tumor-free during the 8 months of the study
(Table 1). In contrast, the majority of CAS-fed mice (77%)
harboring the Wnt1 transgene developed mammary tumors
within this period. Interestingly, the decrease in tumor
incidence with dietary SPI was accompanied by shorter
tumor latency (SPI vs. CAS: 4.65 vs. 6.01 months, P = 0.015).Tumor growth (within two weeks after initial detection) and
tumor weights at sacrifice were similar in both groups
(Table 1). Histopathologic features of mammary tumors
showed predominance of solid carcinoma (Cardiff et al.,
2000) consistent with previous reports (Tsukamoto et al.,
1988). While the frequency of solid carcinoma tended to be
higher for SPI-fed relative to CAS-fed mice, the increase did
not reach statistical significance (Table 1). There was no
evidence of metastasis within the two-week post-tumor
period. Transcript levels of Wnt1 in mammary tumors did not
differ between diet groups and there was no evidence of
increased Wnt activity as measured by tumor c-Myc
expression (data not shown). Data indicate that the reduced
Table 1 Mammary tumor parameters for Wnt1-Tg Mice fed CAS or SPI.
Diet Mice (n) % incidence a Latency b Tumor growth c Tumor weight d % solid carcinoma g
CAS 30 77 6.01 ± 0.33 45.38 ± 9.14 0.0033 ± 0.0001 50
SPI 30 47 e 4.65 ± 0.40 f 46.96 ± 7.81 0.0035 ± 0.0001 70 h
a Incidence measured at 8 months of age.
b Mean tumor onset (months) = age of initial tumor appearance.
c Tumor growth was measured within two weeks after initial tumor detection.
d Tumor weight normalized to body weight.
e P = 0.033 (Fisher's exact test; two-tailed).
f P = 0.015 (t-test).
g n = 20/group.
h P = 0.17 (Fisher's exact test; one-tailed).
1155Diet, CD29hiCD24+14 cell population and mammary tumorigenesisfrequency of the basal (CD29hiCD24+Lin−) epithelial pool in
hyperplastic mammary glands with dietary SPI (Fig. 2) may
relate to lower incidence (risk) of full-blown mammary
tumor formation at a later age.
MECs from SPI-fed Wnt1-Tg mice exhibit
lower repopulating activity and
mammosphere-forming efficiency
Transplantation of MECs into the cleared fat pads of re-
cipient mice results in the reconstitution of a functional
mammary gland, reflecting regenerative/renewal activity
(Shackleton et al., 2006; Visvader, 2009). Previous studies
showed that MECs from hyperplastic Wnt1-Tg mammary
tissues exhibited high in vivo repopulating activity upon
transplantation; this was attributed to an increase in the
size of the MaSC population in Wnt1-Tg mammary glands (Liu
et al., 2004). We determined whether SPI relative to CAS
diet, affected mammary gland repopulation in vivo to
further support the FACS results (Fig. 2). Isolated MECs
from hyperplastic mammary glands of PND75 Wnt1-Tg mice
fed either CAS or SPI beginning at weaning were trans-
planted (10,000 cells per injection) into three-week old
syngeneic wildtype recipient mice fed CAS diet throughout
the study. To preclude host effects in the analyses, each
recipient mouse served as its own control, with right and left
cleared mammary fat pads injected, respectively, with MECs
isolated from PND75 Wnt1-Tg mice fed CAS- or SPI.
Hyperplastic MECs from both CAS- and SPI-fed Wnt1-Tg
mice showed the ability to generate a complete mammary
epithelial tree (90–100% fat pad filled) 8 weeks after trans-
plantation into cleared fat pads of wildtype recipient mice
(Fig. 3a). However, while 6 of 8 MEC transplants from
Wnt-Tg CAS-fed mice generated outgrowths in recipient
mice, only 2 of 8 outgrowths were observed from MECs of
corresponding SPI-fed mice. These findings indicate that
dietary SPI exposure limits the repopulating activity of the
MaSC-enriched (CD29hiCD24+Lin−) epithelial subpopulation
within hyperplastic mammary glands.
To extend these findings, we quantified the mammosphere-
forming ability of MECs isolated from hyperplastic mammary
glands of PND75 Wnt1-Tg mice of the two diet groups. This ex
vivo assay, based on the competence of a small population of
mammary stem/progenitor cells to grow in suspension asspheres (Dontu et al., 2003) constitutes another measure of
regenerative potential. Representative mammospheres form-
ed at passage 2 (P2) from MECs isolated from hyperplastic
mammary glands of CAS- and SPI-fed Wnt-Tg mice are shown
(Fig. 3b). MECs from SPI-fed mice displayed lower mammos-
phere numbers (P2, by 60%) than from control mice (Fig. 3b),
consistent with inhibition by dietary SPI of the expansion of
epithelial subpopulation(s) with renewal capacity.MaSC-enriched (CD29hiCD24+Lin−) epithelial
subpopulation from SPI-fed mice exhibit
enhanced clonogenic but reduced
mammosphere-forming activities
The shorter mammary tumor latency with dietary SPI
exposure (Table 1) suggests higher proliferation of tumor
cells, once tumors are initiated, in SPI-fed mice. The mouse
mammary luminal epithelial population (CD29loCD24hi) is
composed of both luminal progenitors and differentiated
luminal cells (Visvader, 2009), which could not be distin-
guished by the antigen markers used in our FACS assays
(Fig. 2). Similar to transformed basal stem/progenitor cells,
aberrant luminal progenitors exhibit tumorigenic capabili-
ties that sustain mammary tumors (Vaillant et al., 2008; Lim
et al., 2009). These phenotypes are quantifiable ex vivo by
measuring the clonogenic activity of isolated cells, using the
colony formation assay. To examine the possibility that
expansion of the luminal progenitor subpopulation may
underlie the observed decrease in tumor latency with
dietary SPI exposure, despite the reduction in the size of
the mammary CD29hiCD24+Lin− pool (Fig. 2) and lower tumor
incidence (Table 1), MECs from Wnt1-Tg mice fed CAS or SPI
diets were sorted into basal (CD29hiCD24+) and luminal
(CD29loCD24hi) subpopulations by FACS. Each epithelial sub-
population was then subjected to both clonogenic and
mammosphere-formation assays (Fig. 3c). The luminal sub-
population formed colonies upon culture in Matrigel that did
not differ with diet (Fig. 3d), and showed no mammosphere-
forming ability (data not shown). By contrast, the basal
subpopulation isolated from MECs of SPI-fed Wnt-Tg mice
displayed higher clonogenic activity (Fig. 3e) and formed
colonies that were predominantly larger (diameter ≥
100 mm) than those from corresponding mice fed CAS
1156 O.M. Rahal et al.(diameter ≤ 50 mm). Representative colonies at higher
magnification are shown (Fig. 3f). Consistent with that found
for the unfractionated MECs (Fig. 3b), the mammosphere-
forming ability of the basal subpopulation was lower for the SPI-
than for the CAS-fed groups (Fig. 3g), although no significantb
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1157Diet, CD29hiCD24+14 cell population and mammary tumorigenesisThe CD29hiCD24+Lin− epithelial subpopulation
from SPI-fed Wnt1-Tg mice exhibits down-regulated
expression of breast cancer stem/progenitor
cell-related genes
In order to identify gene networks that may relate to lower
mammary tumor incidence with dietary SPI intake (Table 1), we
performed microarray analysis on FACS-sorted CD29hiCD24+Lin−
epithelial subpopulation of hyperplastic mammary glands from
PND75 Wnt1-Tg mice fed CAS or SPI. Unsupervised hierarchical
clustering of gene expression indicated that CAS samples
grouped separately from those of the SPI group (data not
shown). A total of 907 genes were significantly regulated by
at least 1.3-fold with dietary intake of SPI. Of these, 297
were up-regulated (Supplementary Table S4) and 610 were
down-regulated (Supplementary Table S5). The list for SPI
up-regulated genes included candidate tumor suppressor genes
methylated or lost in several cancers, including breast cancer,
such as basonuclin 1 (Bnc1); catenin alpha-like-1 (Ctnnal1);
cytochrome P450, family 24, subfamily a, polypeptide 1
(Cyp24a1); FBJ osteosarcoma oncogene B (Fosb); krüppel-like
factor 11 (Klf11); pyruvate dehydrogenase kinase, isoenzyme 4
(Pdk4); and WNK lysine deficient protein kinase 2 (Wnk2).
Conversely, dietary SPI attenuated the expression of numerous
genes previously shown to be enriched in breast CSCs; these
include aldehyde dehydrogenase 1 (Aldh1); interleukin 6 (Il6);
notch gene homolog 2 (Notch2); and thymus cell antigen 1
(Thy1) (Dontu et al., 2003; Cho et al., 2008; Fu et al., 2010; Park
et al., 2010). Beta 2-microglobulin (B2m), a protein that is
up-regulated in multidrug-resistant tumor cells (Scheffer et al.,
2002), was also decreased in CD29hiCD24+Lin− from hyperplastic
mammary glands of SPI-fed mice. SPI similarly down-regulated
the expression of signal transducer and activator of transcrip-
tion 1 gene (Stat1), recently shown to mediate radiation
resistance of human breast cancer stem cells (Zhang et al.,
2011). Ingenuity Pathway Analysis (IPA) on the 907 annotated
genes regulated by SPI (≥1.3-fold) revealed the top gene
networks (Supplementary Table S6), functional processes
(Supplementary Table S7), and canonical signaling pathways
(Supplementary Table S8). These include those involved inFigure 3 MECs from SPI-fed Wnt1-Tg mice have lower repopulatin
depicting mammary outgrowths from transplantation of freshly isol
Wnt1-Tg mice fed CAS (6/8 outgrowths) or SPI (2/8 outgrowths
conducted, with each experiment representing an individual mouse
mice displayed lower ability to form mammospheres (from secon
(MFU). Representative mammospheres are shown at day 7 of second
MFUs ± SEM of seven independent experiments, where each experim
mouse per diet group and performed in 8–16 replicates. *P ≤ 0.001
FACS-sorted MECs from CAS- and SPI-fed Wnt1-Tg mice. Basal (CD2
were subjected to colony-forming and mammosphere-forming assays
epithelial subpopulations. Data (mean ± SEM) are from three inde
individual mouse and carried out in triplicates. (e) Dietary expos
(CD29hiCD24+Lin) epithelial subpopulation. Data (mean ± SEM) are
representing an individual mouse and carried out in triplicates. *P ≤
(CFU) and mammospheres formed under non-adherent conditions (M
subpopulation from CAS-and SPI-fed Wnt1-Tg mice are shown. Scale b
(CD29hiCD24+Lin−) epithelial subpopulation is reduced with dietary
experiments, with each experiment representing an individual mousorgan development, cancer, metabolic disorders, and cell–cell
communication.
Inflammatory response, chemokine, and cytokine
network genes are potential downstream targets
of dietary SPI in the CD29hiCD24+Lin−
epithelial population
We performed gene set enrichment analysis (False Discovery
Rate (FDR) ≤ 0.25) to distinguish which of the MaSC- and/or
breast CSC-associated genes previously identified to be
associated with normal and aberrant stem cell renewal
were most highly correlated with dietary SPI effects on the
CD29hiCD24+Lin− epithelial population. The major gene
functions down-regulated by SPI in this epithelial subpopu-
lation were related to chemokine and cytokine activity
(FDR b 0.001); inflammation (FDR b 0.004), proliferative
response (FDR b0.094) and oxidative stress (FDR b 0.170).
The heat maps of genes important to inflammation, cytokine
and chemokine signaling, and proliferation which are
down-regulated with dietary SPI and are previously linked
to breast CSC regulation (Korkaya et al., 2011) are shown in
Fig. 4(a–d). Genes in these categories include those for
proinflammatory cytokines tumor necrosis factor (Tnf) and
interleukin 6 (Il6), and for the chemokine (C-C or C-X-C
motifs) ligands Ccl5, Ccl7, and Cxcl5. By contrast, there
were only two gene functions up-regulated with SPI diet;
these were tube development (FDR b 0.151) and transferase
activity (FDR b 0.230); the heat map of genes in the latter
category is shown (Fig. 4e).
The overlapping networks of genes associated with MaSC
and/or breast CSC self-renewal (Aldh, B2m, Il6, Notch2,
Stat1, Thy1), inflammatory response/chemokine signaling
(Ccl8, Ccl11, Ccl21, Cxcl6, Cxcl10, Cxcl11, Tlr, Tnf), and
migration/EMT/metastasis (Bst2, Ezh2, Selp, Tnc, Zeb1),
and whose expression is potentially influenced (directly or
indirectly) by dietary SPI in MaSC-enriched populations,
based on gene array analyses are summarized in Fig. 5a.
Altered expression of a subset of these genes implicated in
stem cell survival (Il6, Stat1), inflammation/chemokineg activity and mammosphere-forming ability. (a) Whole mounts
ated MECs (10,000 cells) from hyperplastic mammary glands of
). Scale bar, 1000 μm. Eight independent experiments were
for each donor and recipient. (b) MECs from SPI-fed Wnt1-Tg
dary passage, P2), quantified as mammosphere-forming units
ary passage (P2). Scale bar, 100 μm. Data represent the mean %
ent utilized mammary epithelial cells isolated from a different
relative to CAS. (c) Schematic diagram for in vitro analysis of
9hiCD24+) and luminal (CD29loCD24+) epithelial subpopulations
. (d) Diet did not influence the colony-forming ability of luminal
pendent experiments, with each experiment representing an
ure to SPI enhanced the clonogenic activity of MaSC-enriched
from three independent experiments, with each experiment
0.05 by t-test. (f) Representative colonies formed in Matrigel
FU) for FACS-sorted MaSC-enriched (CD29hiCD24+Lin) epithelial
ar, 250 μm. (g) Mammosphere-forming ability of MaSC-enriched
SPI exposure. Data (mean ± SEM) are from three independent
e and carried out in triplicates. *P ≤ 0.05, by t-test.
a b Chemokine/
cytokine activity
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Figure 4 Dietary SPI downregulates inflammatory, chemokine, cytokine and proliferation networks in MaSC-enriched (CD29hiCD24+Lin−)
epithelial subpopulation. Heat map representation of SPI-attenuated (a–d) and upregulated (e) MaSC transcripts. (a) Cellular proliferation,
(b) inflammatory response; (c) chemokine/cytokine activity, (d) cytokine biosynthesis and (e) transferase activity. Red indicates positive
correlation; blue, negative correlation.
1158 O.M. Rahal et al.signaling (Il6, Ccl8) and metastasis (Tnc) (Iliopoulos et al.,
2011; Ginestier et al., 2010; Liu et al., 2011; Oskarsson et
al., 2011) was confirmed by QPCR (Figs. 5b–e). The decrease
in IL6 transcripts noted in MaSC-enriched (CD29hiCD24+Lin−)
epithelial subpopulation of mammary glands from PND75
Wnt1-Tg mice fed SPI, relative to those fed CAS was
accompanied by a parallel reduction in serum IL6 levels
(Fig. 5f). Data indicate that dietary SPI negatively regulates
local (CD29hiCD24+Lin− epithelial population) as well as
systemic IL6 production.DiscussionTo the best of our knowledge, the present study constitutes
the first report describing diet-mediated inhibition of theexpansion of the MaSC-enriched (CD29hiCD24+Lin−) epithelial
subpopulation in vivo that may relate to decreased suscep-
tibility to mammary tumor formation. Studies to date have
largely demonstrated dietary factor effects on MaSCs in vitro
using established breast cancer cell lines (Kakarala et al.,
2010; Montales et al., 2012). Using Wnt1-Tg mice, which
develop spontaneous mammary tumors previously shown to
originate from dysregulation of mammary stem/progenitor
cells (Li et al., 2003; Liu et al., 2004), we show that diet may
modify mammary tumor risk and outcome in part, by
influencing the expansion of a distinct epithelial subpopula-
tion with self-renewal capacity. The reduction in MaSC-
enriched population in the hyperplastic mammary glands by
dietary soy (by ~40%) was recapitulated in a similar reduction
in the CSC (Thy+) population (by ~60%) but not in the luminal
subpopulation. While speculative, the lack of dietary SPI
effects on the luminal subpopulations could mean that
ab d
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Figure 5 Dietary SPI regulation of molecules related to breast CSC survival, inflammation, and metastasis in MaSC-enriched
(CD29hiCD24+Lin−) epithelial subpopulation within hyperplastic mammary tissues from Wnt1-Tg mice. (a) Molecular network from
pathway analysis indicating dietary SPI suppression of molecules involved in MaSC and/or breast CSC survival, inflammatory/
chemokine network, and migration/metastasis. Green indicates downregulation. QPCR analyses of transcripts for Il6 (b), Stat1 (c),
Ccl8 (d), and Tnc (e) in MaSC-enriched population (n = 4–6 independent samples, where each sample represents RNAs pooled from 2 to
3 mice per diet group) as a function of dietary CAS or SPI exposure. 18s rRNA was used as normalizing control; *P ≤ 0.05 relative to CAS.
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1159Diet, CD29hiCD24+14 cell population and mammary tumorigenesissoy-associated bioactive factors may (directly or indirectly)
preferentially target cells that give rise to tumors with
non-luminal A molecular subtype (Sørlie et al., 2001). We
further show that the limited expansion of the basal
(CD29hiCD24+Lin−) epithelial subpopulation with dietary SPI
is associated with suppression of pro-inflammatory cytokine,
chemokine and proliferative gene expression in this epithe-
lial subpopulation and with reductions in systemic levels of
the steroid hormones estradiol and progesterone and the
cytokine IL-6, all of which are considered to promote breastcancer risk. Our collective data suggest that diet-regulated
hormonal cues can impact MaSC self-renewal programs and
by so doing, limit the transformation of MaSC to cancer stem
cells for tumor initiation.
A major feature of the SPI-altered gene network in the
CD29hiCD24+Lin− epithelial subpopulation is a suppressed
cytokine and chemokine transcriptional signature. Based on
previously reported signaling pathways involving cytokines in
this gene signature, we identify IL6 as a candidate target of
SPI effects within the MaSC population. By reducing systemic
1160 O.M. Rahal et al.levels and MaSC-enriched production of IL6, dietary SPI may
effectively block a number of critical pathways in tumor
initiation and subsequent tumor survival and metastasis.
While the mechanistic association between SPI-induction of
IL6 and inhibition of MaSC expansion was not evaluated in
the present study, our findings are consistent with previous
reports that IL6 promotes breast CSC self-renewal (Iliopoulos
et al., 2011) and fosters the positive feedback loop between
MaSCs and breast CSCs (Iliopoulos et al., 2011). Moreover,
our findings that SPI diet reduced the expression of a
preponderance of genes with pro-inflammatory activities in
the CD29hiCD24+Lin− epithelial subpopulation highlight the
functional importance of controlling the inflammatory milieu
for breast cancer prevention (Cabodi and Taverna, 2010).
Further, they support the clinical importance of an extensive
search for bioactive food components with anti-inflammatory
activities for further investigations into dietary cues for breast
cancer prevention.
Our findings of decreased systemic progesterone, taken
together with the observed reduction of the MaSC-enriched
(CD29hiCD24+Lin−) epithelial subpopulation and lower tumor
incidence with dietary SPI intake, are consistent with the
reduced incidence of mammary tumors in mice null for
progesterone receptor when administered with the chemical
carcinogen DMBA (Lydon et al., 1999). Moreover, the transient
breast cancer risk that lasts for a few years after a full-term
pregnancy (Brit et al., 2007) has been attributed to the
expansion of mammary stem cells during this period of high
progesterone exposure (Tiede et al., 2009). Similarly, the
lower levels of estradiol-17β in Wnt1-Tg mice fed SPI are
consistent with high circulating estrogens as a risk factor for
breast cancer (Litton et al., 2012). While MaSCs lack expression
of receptors for estrogen and progesterone (Asselin-Labat et
al., 2006, 2010; Joshi et al., 2010), they are subject to estrogen-
and progesterone-induced expansion involving the stem cell
niche via paracrine signaling. The pathway(s) linking the decline
in systemic levels of progesterone, estrogen and IL6 by
dietary SPI with the reduction in the frequency of a distinct
epithelial subpopulation with renewal capacity remains to
be determined and is the subject of current investigations in
our group.
A paradoxical outcome of dietary SPI exposure is the shorter
latency of Wnt1-generated mammary tumors, despite the
significant reduction in tumor incidence in SPI-fed mice. We
previously reported that in female rats exposed to SPI and
administered with the direct acting carcinogen N-methyl-
nitrosourea (to induce mammary tumors), SPI reduction of
tumor incidencewas associatedwith higher grade tumors in rats
that developed tumors (Simmen et al., 2005). Herein, we
suggest a plausible explanation for this paradox based on
the distinct functional responses of the MaSC-enriched
(CD29hiCD24+Lin) epithelial subpopulation to diet. We
found that relative to the control diet, exposure to SPI can
reduce basal (MaSC-enriched) cell expansion (measured by
mammosphere-forming ability) while enhancing its prolif-
erative phenotype (measured by colony-formation assay).
The molecular basis for the opposing actions of dietary soy
on the same target population is currently unknown, but
may involve distinct biological effects of associated bioactive
components. Our findings highlight the complex nature of foods
and their context-dependent effects and provide a cautionary
note when considering dietary/nutritional strategies for themanagement of breast cancer patients or in women at high risk
for the disease.
Our approach of utilizing hyperplastic MEC cells for eval-
uating dietary effects on the expansion of the basal-enriched
(CD29hiCD24+Lin−) MaSC and CSC (CD29hiThy1+CD24+) popula-
tions allowed us to demonstrate a potential (predictive)
correlation between the sizes of these populations and
subsequent risk formammary tumors. Given this focus, dietary
effects on the size of the CSC population in mammary tumors
were not assessed. In a recent report, early Wnt1 over-
expressionwas found to drastically alter the epithelial ontogeny
of the mammary gland and hence, the developmental fate of
mammary stem and progenitor cells (Van Amerongen et al.,
2012). Hence, future studies will address whether the dietary
effects shown here are recapitulated in normal MaSC of adult
mammary glands in wildtype mice, utilizing similar approaches
described herein, including limiting dilution transplantation
studies for quantitative determination of stem cell frequency.
We consider the absence of the latter data as a limitation to the
present study.
In summary, our in vivo and ex vivo studies provide
evidence for the functional impact of diet on specific
epithelial subpopulations that may relate to breast cancer
risk. Moreover, our findings raise the interesting possibility
that by blocking key regulatory nodes linking steroid
hormone signaling and inflammation, early dietary interven-
tions can interfere with the expansion of specific epithelial
subpopulations with high regenerative/renewal capacity.
Our results suggest that diet-regulated cues can be further
explored for breast cancer risk assessment and prevention.
Supplementary data to this article can be found online at
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